Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

Margaret D. Weiss,Andrew J. Cutler,Scott H. Kollins,Graeme A.E. Donnelly

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

2021

Margaret D. Weiss
Andrew J. Cutler
Scott H. Kollins
Graeme A.E. Donnelly

Objectives: To study the safety and efficacy of the long-acting methylphenidate formulation PRC-063 in adolescents with attention-deficit/hyperactivity disorder (ADHD). Methods: Adolescents 12 to ≤...

Keywords:

Clinical trial
double blind
Pediatrics
open label
Attention deficit hyperactivity disorder
Medicine
long acting
Stimulant
Methylphenidate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations